Michael Gelband ExodusPoint Capital Management
Michael Gelband is a co-founder of ExodusPoint Capital Management, a multi-strategy hedge fund launched by veterans of larger alternative platforms. The firm pursues diversified strategies across asset classes with a focus on risk-managed absolute returns. Gelband’s firm is followed as part of the newer generation of multi-strategy complexes.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fidelity National Information Services
FIS
|
+$365M |
| 2 |
Global Payments
GPN
|
+$250M |
| 3 |
NiSource
NI
|
+$109M |
| 4 |
Constellation Brands
STZ
|
+$107M |
| 5 |
Xcel Energy
XEL
|
+$105M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
VMW
VMware, Inc
VMW
|
+$95.7M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$89.4M |
| 3 |
ExxonMobil
XOM
|
+$84.7M |
| 4 |
Southern Company
SO
|
+$79.2M |
| 5 |
Emerson Electric
EMR
|
+$61.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 9.26% |
| 2 | Industrials | 7.84% |
| 3 | Utilities | 7.6% |
| 4 | Healthcare | 5.4% |
| 5 | Real Estate | 4.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
876
Leidos
LDOS
$17.4B
| $831K | 0.01% |
7,680
-22,653
| -75% | -$2.31M |
|
877
DocGo
DCGO
$39.2M
| $830K | 0.01% |
+148,481
| New | +$853K |
|
878
International Money Express
IMXI
$428M
| $830K | 0.01% |
37,581
+7,882
| +27% | +$151K |
|
879
Mueller Water Products
MWA
$3.91B
| $830K | 0.01% |
+57,633
| New | +$762K |
|
880
CACI
CACI
$14B
| $828K | 0.01% |
2,558
-3,800
| -60% | -$1.23M |
|
|
DAY
881
DELISTED
Dayforce
DAY
| $828K | 0.01% |
12,342
+2,809
| +29% | +$192K |
|
882
Gold Fields
GFI
$42.1B
| $827K | 0.01% |
+57,187
| New | +$791K |
|
883
Trex
TREX
$4.79B
| $826K | 0.01% |
9,977
-65,650
| -87% | -$4.35M |
|
884
Aemetis
AMTX
$136M
| $822K | 0.01% |
156,908
+34,110
| +28% | +$161K |
|
885
Horace Mann Educators
HMN
$2.07B
| $819K | 0.01% |
+25,050
| New | +$804K |
|
|
SAVE
886
PUT
DELISTED
Spirit Airlines, Inc.
SAVE
| $819K | 0.01% |
+50,000
| New | +$719K |
|
887
Trupanion
TRUP
$1.38B
| $817K | 0.01% |
+26,793
| New | +$710K |
|
888
Carlyle Secured Lending
CGBD
$784M
| $816K | 0.01% |
+54,574
| New | +$794K |
|
889
Global E Online
GLBE
$6.8B
| $812K | 0.01% |
+20,480
| New | +$738K |
|
890
Deckers Outdoor
DECK
$12.4B
| $811K | 0.01% |
7,284
+3,984
| +121% | +$405K |
|
891
Constellation Energy
CEG
$96.4B
| $810K | 0.01% |
+6,931
| New | +$809K |
|
|
SYRS
892
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $806K | 0.01% |
103,522
-4,615
| -4% | -$15.8K |
|
893
Workday
WDAY
$49.5B
| $805K | 0.01% |
2,915
-24,131
| -89% | -$5.75M |
|
|
UDMY
894
DELISTED
Udemy
UDMY
| $798K | 0.01% |
+54,189
| New | +$675K |
|
|
BBT
895
Beacon Financial Corp
BBT
$2.65B
| $796K | 0.01% |
32,061
+20,313
| +173% | +$438K |
|
|
IAS
896
DELISTED
Integral Ad Science
IAS
| $793K | 0.01% |
55,081
+28,486
| +107% | +$381K |
|
897
Frontdoor
FTDR
$5.78B
| $790K | 0.01% |
22,441
-40,076
| -64% | -$1.33M |
|
898
Assurant
AIZ
$14.1B
| $788K | 0.01% |
4,676
-4,898
| -51% | -$779K |
|
899
Kinross Gold
KGC
$38.8B
| $788K | 0.01% |
130,213
-143,027
| -52% | -$782K |
|
900
Universal Insurance Holdings
UVE
$1.23B
| $782K | 0.01% |
48,955
+34,810
| +246% | +$542K |
|
Similar funds
Michael Gelband's Q4 2023 Portfolio in Review
As of Q4 2023, Michael Gelband held 2,187 positions worth $15.2B, up 46% from $10.5B the previous quarter. Its ten largest holdings account for 45% of the portfolio.
Michael Gelband deployed $3.57B of net new capital in Q4 2023, opening 553 new positions and adding to 436 existing holdings. Its largest new stake was Fidelity National Information Services: 6,650,397 shares worth $399M.
By sector, the portfolio is most concentrated in Technology at 9.3% of assets, down from 10% a quarter earlier, followed by Industrials and Utilities.
On the sell side, the largest reduction was Merck, an estimated $48.2M trimmed.
- Michael Gelband's largest Q4 2023 buy was Fidelity National Information Services: 6,650,397 shares worth $399M.
- Michael Gelband added most to Global Payments in Q4 2023, an estimated $250M increase.
- Michael Gelband's biggest Q4 2023 reduction was Merck, cutting an estimated $48.2M.
- Michael Gelband fully exited VMware, Inc in Q4 2023, selling an estimated $95.7M.
- Michael Gelband's ten largest holdings make up 45% of its $15.2B portfolio in Q4 2023.
- Michael Gelband opened 553 new positions and closed 789 in Q4 2023.
- Michael Gelband's portfolio value rose 46% quarter-over-quarter to $15.2B.
Based on ExodusPoint Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.